BETHESDA, MD 10 October 2013—This year’s World Congress of Pharmacy and Pharmaceutical Sciences, organized by the International Pharmaceutical Federation (FIP), attracted more than 3000 participants from 107 countries.
The congress featured business meetings, educational programs, poster sessions, and other activities from August 31 through September 5 in the heart of Ireland’s largest city, Dublin.
Basel Statements on hospital pharmacy practice. FIP’s Hospital Pharmacy Section has added a research component to ongoing work with the Basel Statements (PDF), the 75 consensus statements on the future of hospital pharmacy practice, said Marianne F. Ivey, the section’s vice president representing the Americas.
Ivey, a professor of pharmacy practice at the University of Cincinnati, said initial research has focused on drug formularies in hospitals.
Research activities are being driven by Rebekah Moles, the section’s assistant secretary, Ivey said.
Moles established the World Hospital Pharmacy Research Consortium at the University of Sydney in Australia, where she is a senior lecturer.
Known by the abbreviation WHoPReC, the consortium describes itself as “an independent global network of researchers aimed at producing high quality, internationally focused research on hospital pharmacy practices to improve health outcomes.”
Diane Ginsburg, with the University of Texas at Austin, participates in the consortium, which is working to determine hospital-level progress in implementing the Basel Statements, Ivey said.
“The surveys [by the consortium] are rich with a lot of information,” Ivey said, “and I think they’re going to provide a lot of ideas for what people need” with regard to education and practice models.
Programs, posters. While at the congress, Ivey and other members of the section’s leadership met with representatives of FIP’s scientifically oriented special interest groups. She said the goal is for the section at future congresses to offer educational programs that incorporate scientific material, such as the cellular-level effects of vaccines and monoclonal antibodies and the chemistry aspects of drug compounding.
The section’s poster session had upward of 170 presentations, by far the most of any of FIP’s sections, Ivey said.
A group from Nigeria won the grand prize in the section’s poster competition. The title of the poster was “Outcomes of Pharmaceutical Care Interventions in Type 2 Diabetes Mellitus Patients: A Prospective Pilot Study at Federal Teaching Hospital Abakaliki, Ebonyi State Nigeria.”
Awards. Three members of the Hospital Pharmacy Section received awards during the congress’s opening ceremony on September 1.
William A. Zellmer received the FIP Lifetime Achievement in Pharmaceutical Practice Award. Zellmer served as vice chair of the planning committee for the 2008 Global Conference on the Future of Hospital Pharmacy, where consensus on the Basel Statements was reached. He has also served as a consultant on strategic issues for the European Association of Hospital Pharmacists and the Saudi Pharmaceutical Society.
Toby Clark and Andrew L. Gray became fellows of FIP.
Clark served as the Hospital Pharmacy Section’s vice president for the Americas from 1998 to 2006 and treasurer in 2006–10.
Gray is the chairman of the Board of Pharmaceutical Practice and the Hospital Pharmacy Section’s immediate past president. He served as the president in 2006–10.
New FIP policy statement, other business. During the congress, the national organizations belonging to FIP adopted a policy (PDF) on the effective use of pharmacists in improving maternal, newborn, and child health.
Philip J. Schneider, a vice president of FIP and associate dean for the University of Arizona College of Pharmacy in Phoenix, said the idea for such a policy arose in part from the World Health Organization (WHO).
Oftentimes when WHO establishes an area of priority, he explained, FIP considers whether a pharmacist could make a contribution. In the case of maternal, newborn, and child health, FIP decided that yes, pharmacists could contribute, he said.
Schneider said the Ethics in Pharmacy Working Group, cochaired by Zellmer, presented its report on ethics and professional autonomy to FIP’s member organizations.
The report, Schneider said, may go to the World Health Professions Alliance, which includes FIP and the World Medical Association.
A possible result is an official statement relevant to multiple health professions. In May, the World Health Professions Alliance issued a statement (PDF) on interprofessional collaborative practice. Schneider said this statement came about because FIP had taken its own policy statement on the subject to the alliance and generated interest in the value of collaborative practice.
FIP, through the efforts of a group chaired by Schneider, now has a working definition for the term the responsible use of medicines. This phrase was part of FIP’s Centennial Declaration (PDF), issued last year.
He said the working definition deals with the patient, caregivers, the pharmacist, other people in the health care system involved in medication use, and the supply chain.
In the year since FIP celebrated its centennial, Schneider said, the organization has been sort of “rebooting” itself. Underway are an update of the statutes and evaluations of the statements and guidelines, some of which were adopted more than 15 years ago. He said North America’s representative on the commission updating the statutes is Thomas E. Menighan, executive vice president of the American Pharmacists Association.
The meeting in Dublin marked the end of service by Henri R. Manasse, Jr. as the FIP Professional Secretary. In this position, Manasse handled the organization of FIP’s activities concerning pharmacy practitioners. He served two terms, starting in 2005 when he was the executive vice president of ASHP.
FIP will hold its 2014 congress, August 30 through September 4, in Bangkok, Thailand.
The theme will be “Pharmacists—Ensuring Access to Health: Exploring Our Impact on Providing Medicines, Care and Information.”